Investigation of antigen specific lymphocyte responses in healthy horses vaccinated with an inactivated West Nile virus vaccine

Veterinary Immunology and Immunopathology

Volumn 126, Issue 3-4, 2008, Pages 293-301

  Davis, Elizabeth G ^a   Zhang, Yuwen ^a   Tuttle, John ^b   Hankins, Kevin ^b   Wilkerson, Melinda ^a  

^a KANSAS STATE UNIVERSITY   (United States)

^b ZOETIS   (United States)

Author keywords

Cell mediated immunity; Equine; WNV vaccination

Indexed keywords

GAMMA INTERFERON; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS; INACTIVATED VIRUS VACCINE; INTERLEUKIN 4; LYMPHOCYTE ANTIGEN; NEUTRALIZING ANTIBODY; WEST NILE VACCINE;

ANIMAL CELL; ANTIBODY RESPONSE; ANTIBODY TITER; ANTIGEN SPECIFICITY; ARTICLE; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; FEMALE; HORSE; HUMORAL IMMUNITY; IMMUNE RESPONSE; LYMPHOCYTE PROLIFERATION; MALE; NONHUMAN; PROTEIN EXPRESSION; SERODIAGNOSIS; VACCINATION; WEST NILE FLAVIVIRUS;

ANALYSIS OF VARIANCE; ANIMALS; CD4-POSITIVE T-LYMPHOCYTES; FLOW CYTOMETRY; HORSE DISEASES; HORSES; IMMUNOPHENOTYPING; INTERFERON-GAMMA; INTERLEUKIN-4; PLAQUE ASSAY; WEST NILE FEVER; WEST NILE VIRUS VACCINES;

EQUIDAE; RNA VIRUSES; WEST NILE VIRUS;

EID: 56149083968     PISSN: 01652427     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vetimm.2008.08.007     Document Type: Article

References (32)

1. Autorino G.L., Battisti A., Deubel V., Ferrari G., Forletta R., Giovannini A., Lelli R., Murri S., and Scicluna M.T. West Nile virus epidemic in horses, Tuscany region, Italy. Emerg. Infect. Dis. 8 (2002) 1372-1378
2. Blitvich B.J. Transmission dynamics and changing epidemiology of West Nile virus. Anim. Health Res. Rev. (2008) 1-16
3. Burt F.J., Grobbelaar A.A., Leman P.A., Anthony F.S., Gibson G.V., and Swanepoel R. Phylogenetic relationships of southern African West Nile virus isolates. Emerg. Infect. Dis. 8 (2002) 820-826
4. Cantile C., Del P.F., Di G.G., and Arispici M. Pathologic and immunohistochemical findings in naturally occurring West Nile virus infection in horses. Vet. Pathol. 38 (2001) 414-421
5. Castillo-Olivares J., de Vries A.A., Raamsman M.J., Rottier P.J., Lakhani K., Westcott D., Tearle J.P., Wood J.L., Mumford J.A., Hannant D., and Davis-Poynter N.J. Evaluation of a prototype sub-unit vaccine against equine arteritis virus comprising the entire ectodomain of the virus large envelope glycoprotein (G(L)): induction of virus-neutralizing antibody and assessment of protection in ponies. J. Gen. Virol. 82 (2001) 2425-2435
6. Castillo-Olivares J., and Wood J. West Nile virus infection of horses. Vet. Res. 35 (2004) 467-483
7. Dauphin G., Zientara S., Zeller H., and Murgue B. West Nile: worldwide current situation in animals and humans. Comp. Immunol. Microbiol. Infect. Dis. 27 (2004) 343-355
8. Davidson A.H., Traub-Dargatz J.L., Rodeheaver R.M., Ostlund E.N., Pedersen D.D., Moorhead R.G., Stricklin J.B., Dewell R.D., Roach S.D., Long R.E., Albers S.J., Callan R.J., and Salman M.D. Immunologic responses to West Nile virus in vaccinated and clinically affected horses. J. Am. Vet. Med. Assoc. 226 (2005) 240-245
9. Davis E.G., Rush B.R., and Blecha F. Increases in cytokine and antimicrobial peptide gene expression in horses by immunomodulation with Propionibacterium acnes. Vet. Ther. 4 (2003) 5-11
10. Durand B., Chevalier V., Pouillot R., Labie J., Marendat I., Murgue B., Zeller H., and Zientara S. West Nile virus outbreak in horses, southern France, 2000: results of a serosurvey. Emerg. Infect. Dis. 8 (2002) 777-782
11. El G.H., Minke J.M., Rehder J., Richard S., Edlund T.C., Dinic S., Andreoni C., Audonnet J.C., Nordgren R., and Juillard V. A West Nile virus (WNV) recombinant canarypox virus vaccine elicits WNV-specific neutralizing antibodies and cell-mediated immune responses in the horse. Vet. Immunol. Immunopathol. 123 (2008) 230-239
12. Epp, T.Y., Waldner, C., West, K., Leighton, F.A., Townsend, H., 2005. Efficacy of vaccination for West Nile Virus in Saskatchewan Horses. AAEP, pp. 180-182.
13. Epp T., Waldner C., Leighton F.A., Berke O., and Townsend H.G. Seroprevalence and risk factors for infection with West Nile virus in Saskatchewan horses, 2003. Can. J. Vet. Res. 71 (2007) 256-263
14. Epp T., Waldner C., and Townsend H.G. A case-control study of factors associated with development of clinical disease due to West Nile virus, Saskatchewan 2003. Equine Vet. J. 39 (2007) 498-503
15. Fulcher D., and Wong S. Carboxyfluorescein succinimidyl ester-based proliferative assays for assessment of T cell function in the diagnostic laboratory. Immunol. Cell Biol. 77 (1999) 559-564
16. Gardner I.A., Wong S.J., Ferraro G.L., Balasuriya U.B., Hullinger P.J., Wilson W.D., Shi P.Y., and MacLachlan N.J. Incidence and effects of West Nile virus infection in vaccinated and unvaccinated horses in California. Vet. Res. 38 (2007) 109-116
17. Hayes E.B., Komar N., Nasci R.S., Montgomery S.P., O'Leary D.R., and Campbell G.L. Epidemiology and transmission dynamics of West Nile virus disease. Emerg. Infect. Dis. 11 (2005) 1167-1173
18. Keller B.C., Fredericksen B.L., Samuel M.A., Mock R.E., Mason P.W., Diamond M.S., and Gale Jr. M. Resistance to alpha/beta interferon is a determinant of West Nile virus replication fitness and virulence. J. Virol. 80 (2006) 9424-9434
19. Komar N. West Nile virus: epidemiology and ecology in North America. Adv. Virus Res. 61 (2003) 185-234
20. Liu W.J., Wang X.J., Clark D.C., Lobigs M., Hall R.A., and Khromykh A.A. A single amino acid substitution in the West Nile virus nonstructural protein NS2A disables its ability to inhibit alpha/beta interferon induction and attenuates virus virulence in mice. J. Virol. 80 (2006) 2396-2404
21. McLean R.G., Ubico S.R., Bourne D., and Komar N. West Nile virus in livestock and wildlife. Curr. Top. Microbiol. Immunol. 267 (2002) 271-308
22. Pedersen L.G., Castelruiz Y., Jacobsen S., and Aasted B. Identification of monoclonal antibodies that cross-react with cytokines from different animal species. Vet. Immunol. Immunopathol. 88 (2002) 111-122
23. Salazar P., Traub-Dargatz J.L., Morley P.S., Wilmot D.D., Steffen D.J., Cunningham W.E., and Salman M.D. Outcome of equids with clinical signs of West Nile virus infection and factors associated with death. J. Am. Vet. Med. Assoc. 225 (2004) 267-274
24. Samuel M.A., and Diamond M.S. Alpha/beta interferon protects against lethal West Nile virus infection by restricting cellular tropism and enhancing neuronal survival. J. Virol. 79 (2005) 13350-13361
25. Schuffenecker I., Peyrefitte C.N., el H.M., Murri S., Leblond A., and Zeller H.G. West Nile virus in Morocco, 2003. Emerg. Infect. Dis. 11 (2005) 306-309
26. Schuler L.A., Khaitsa M.L., Dyer N.W., and Stoltenow C.L. Evaluation of an outbreak of West Nile virus infection in horses: 569 cases (2002). J. Am. Vet. Med. Assoc. 225 (2004) 1084-1089
27. Seino K.K., Long M.T., Gibbs E.P., Bowen R.A., Beachboard S.E., Humphrey P.P., Dixon M.A., and Bourgeois M.A. 28 day vaccine efficacy in equine WNV encephalitis model. Clin. Vaccine Immunol. (2007)
28. Sitati E.M., and Diamond M.S. CD4+ T-cell responses are required for clearance of West Nile virus from the central nervous system. J. Virol. 80 (2006) 12060-12069
29. Ward M.P. Spread of equine West Nile virus encephalomyelitis during the 2002 Texas epidemic. Am. J. Trop. Med. Hyg. 74 (2006) 1090-1095
30. Ward M.P., Levy M., Thacker H.L., Ash M., Norman S.K., Moore G.E., and Webb P.W. Investigation of an outbreak of encephalomyelitis caused by West Nile virus in 136 horses. J. Am. Vet. Med. Assoc. 225 (2004) 84-89
31. Ward M.P., Schuermann J.A., Highfield L.D., and Murray K.O. Characteristics of an outbreak of West Nile virus encephalomyelitis in a previously uninfected population of horses. Vet. Microbiol. 118 (2006) 255-259
32. Zeller H.G., and Schuffenecker I. West Nile virus: an overview of its spread in Europe and the Mediterranean basin in contrast to its spread in the Americas. Eur. J. Clin. Microbiol. Infect. Dis. 23 (2004) 147-156